Literature DB >> 31126

Trimolol: effect on intraocular pressure in chronic open-angle glaucoma.

S A Obstbaum, M A Galin, I M Katz.   

Abstract

Timolol maleate is an effective agent of reducing intraocular pressure in patients with chronic open-angle glaucoma. To date, there are no adverse side effects demonstrable with use of this medication. Its mechanism of action is not clearly delineated but preliminary data suggest an effect on outflow facility.

Entities:  

Mesh：

Substances：

Year:  1978        PMID： 31126

Source DB:  PubMed          Journal:  Ann Ophthalmol        ISSN： 0003-4886


  6 in total

Review 1.  Pharmacological therapy for glaucoma: a review.

Authors:  P F Hoyng; L M van Beek
Journal:  Drugs       Date:  2000-03       Impact factor: 9.546

2.  A blind randomised cross-over trial comparing metipranolol 0.3% with timolol 0.25% in open-angle glaucoma: a pilot study.

Authors:  K B Mills; G Wright
Journal:  Br J Ophthalmol       Date:  1986-01       Impact factor: 4.638

3.  Interaction of timolol and adrenaline.

Authors:  A Ohrström; O Kättström
Journal:  Br J Ophthalmol       Date:  1981-01       Impact factor: 4.638

4.  Effects of timolol on corneal sensitivity and tear production.

Authors:  Y Kitazawa; H Tsuchisaka
Journal:  Int Ophthalmol       Date:  1980-12       Impact factor: 2.031

5.  Study of the additive effect of timolol and epinephrine in lowering intraocular pressure.

Authors:  J V Thomas; D L Epstein
Journal:  Br J Ophthalmol       Date:  1981-09       Impact factor: 4.638

6.  Managing refractory glaucoma with a fixed combination of bimatoprost (0.03%) and timolol (0.5%).

Authors:  Moataz E Gheith; Jason R Mayer; Ghada A Siam; Daniela S Monteiro de Barros; Tricia L Thomas; L Jay Katz
Journal:  Clin Ophthalmol       Date:  2008-03
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.